ArticlePloS one2013

Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour.

Benjamin Weide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.